Literature DB >> 17255340

Central role of protein kinase Cepsilon in constitutive activation of ERK1/2 and Rac1 in the malignant cells of hairy cell leukemia.

Joseph R Slupsky1, Aura S Kamiguti, Robert J Harris, John C Cawley, Mirko Zuzel.   

Abstract

We have previously identified the presence of Ras/Raf-independent constitutive activation of extracellular signal-regulated kinase (ERK) in the hairy cells (HCs) of hairy cell leukemia. The aim of the present study was to characterize the signaling components involved in this activation and their relationship to the reported activation of Rac1. We found that both Rac1 and ERK activation in HCs are downstream of active Src and protein kinase C (PKC). Inhibition with toxin B showed that Rac1 plays no role in ERK activation in HCs. However, toxin B inhibited p60src and the Rac1-GEF Vav, demonstrating a positive feedback/activation of p60src by Rac1. Treatment with specific small interfering RNA for various PKC isoforms, or with PKC isoform-specific inhibitors, demonstrated a central role for PKCepsilon in the constitutive activation of Rac1 and ERK in HCs. PKCepsilon and active ERK were mutually associated and co-localized with mitochondria in HCs. Furthermore, active PKCepsilon was nitrated on tyrosine, pointing to a reactive oxygen species-dependent mechanism of activation. By being involved in activation of ERK and Rac1, PKCepsilon plays roles in both the survival of HCs and in the cytoskeletal dynamics responsible for the distinctive morphology and tissue homing of these cells. Our study therefore describes novel aspects of signaling important for the pathogenesis of hairy cell leukemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255340      PMCID: PMC1851876          DOI: 10.2353/ajpath.2007.060557

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  A new monoclonal antibody which selectively recognizes the active form of Src tyrosine kinase.

Authors:  H Kawakatsu; T Sakai; Y Takagaki; Y Shinoda; M Saito; M K Owada; J Yano
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

Review 2.  Protein kinase C: structure, function, and regulation.

Authors:  A C Newton
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

3.  Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation.

Authors:  S P Soltoff
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

4.  Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase C epsilon and delta in neonatal rat ventricular myocytes.

Authors:  M C Heidkamp; A L Bayer; J L Martin; A M Samarel
Journal:  Circ Res       Date:  2001-11-09       Impact factor: 17.367

5.  Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells.

Authors:  A Besson; A Davy; S M Robbins; V W Yong
Journal:  Oncogene       Date:  2001-11-01       Impact factor: 9.867

6.  Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line.

Authors:  V Roman; H Zhao; J M Fourneau; A Marconi; N Dugas; B Dugas; F Sigaux; J P Kolb
Journal:  Leukemia       Date:  2000-04       Impact factor: 11.528

7.  Interferon-alpha downregulates the abnormal intracytoplasmic free calcium concentration of tumor cells in hairy cell leukemia.

Authors:  E Génot; G Bismuth; L Degos; F Sigaux; J Wietzerbin
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

Review 8.  The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival.

Authors:  Desmond N Jackson; David A Foster
Journal:  FASEB J       Date:  2004-04       Impact factor: 5.191

9.  MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo.

Authors:  Daniel J Lips; Orlando F Bueno; Benjamin J Wilkins; Nicole H Purcell; Robert A Kaiser; John N Lorenz; Laure Voisin; Marc K Saba-El-Leil; Sylvain Meloche; Jacques Pouysségur; Gilles Pagès; Leon J De Windt; Pieter A Doevendans; Jeffery D Molkentin
Journal:  Circulation       Date:  2004-04-19       Impact factor: 29.690

10.  Constitutive activation of extracellular signal-regulated kinase 2 by synergistic point mutations.

Authors:  M A Emrick; A N Hoofnagle; A S Miller; L F Ten Eyck; N G Ahn
Journal:  J Biol Chem       Date:  2001-10-08       Impact factor: 5.157

View more
  12 in total

1.  Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients.

Authors:  E Masselli; C Carubbi; G Gobbi; P Mirandola; D Galli; S Martini; S Bonomini; M Crugnola; L Craviotto; F Aversa; M Vitale
Journal:  Leukemia       Date:  2015-06-19       Impact factor: 11.528

Review 2.  The role of Rac in tumor susceptibility and disease progression: from biochemistry to the clinic.

Authors:  Victoria Casado-Medrano; Martin J Baker; Cynthia Lopez-Haber; Mariana Cooke; Shaofei Wang; Maria J Caloca; Marcelo G Kazanietz
Journal:  Biochem Soc Trans       Date:  2018-07-31       Impact factor: 5.407

3.  BRAF mutations in hairy-cell leukemia.

Authors:  Enrico Tiacci; Vladimir Trifonov; Gianluca Schiavoni; Antony Holmes; Wolfgang Kern; Maria Paola Martelli; Alessandra Pucciarini; Barbara Bigerna; Roberta Pacini; Victoria A Wells; Paolo Sportoletti; Valentina Pettirossi; Roberta Mannucci; Oliver Elliott; Arcangelo Liso; Achille Ambrosetti; Alessandro Pulsoni; Francesco Forconi; Livio Trentin; Gianpietro Semenzato; Giorgio Inghirami; Monia Capponi; Francesco Di Raimondo; Caterina Patti; Luca Arcaini; Pellegrino Musto; Stefano Pileri; Claudia Haferlach; Susanne Schnittger; Giovanni Pizzolo; Robin Foà; Laurent Farinelli; Torsten Haferlach; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  N Engl J Med       Date:  2011-06-11       Impact factor: 91.245

4.  Proteins kinase Cɛ is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes.

Authors:  M C Caino; C Lopez-Haber; J Kim; D Mochly-Rosen; M G Kazanietz
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

5.  A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines.

Authors:  Piotr Jasinski; Brandon Welsh; Jorge Galvez; David Land; Pawel Zwolak; Lori Ghandi; Kaoru Terai; Arkadiusz Z Dudek
Journal:  Invest New Drugs       Date:  2007-10-24       Impact factor: 3.850

6.  Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells.

Authors:  Vivian R Ruvolo; Kul B Karanjeet; Todd F Schuster; Rhoderick Brown; Yibin Deng; Edward Hinchcliffe; Peter P Ruvolo
Journal:  J Signal Transduct       Date:  2010-01-01

7.  HepaCAM inhibits clear cell renal carcinoma 786-0 cell proliferation via blocking PKCε translocation from cytoplasm to plasma membrane.

Authors:  Bing Tan; Jinxiang Tan; Hongfei Du; Zhen Quan; Xiangdong Xu; Xiaoliang Jiang; Chunli Luo; Xiaohou Wu
Journal:  Mol Cell Biochem       Date:  2014-02-11       Impact factor: 3.396

Review 8.  Role of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia development.

Authors:  André L Mencalha; Stephany Corrêa; Eliana Abdelhay
Journal:  Onco Targets Ther       Date:  2014-07-08       Impact factor: 4.147

9.  Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential.

Authors:  Philip Savage
Journal:  BMC Cancer       Date:  2015-01-21       Impact factor: 4.430

10.  Variant B cell receptor isotype functions differ in hairy cell leukemia with mutated BRAF and IGHV genes.

Authors:  Nicola J Weston-Bell; Francesco Forconi; Hanneke C Kluin-Nelemans; Surinder S Sahota
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.